All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for IONIS PHARMACEUTICALS, INC. · Biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income · posted Apr 17, 2026

Official filing document

Bills named in this filing 5

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 1672
Maintaining Investments in New Innovation Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 1

Health Issues

Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.